Chinamedonline

China medical information service platform,global B2B medical apparatus and instruments trading platform!

[Kidney Disease Forum @KidneyDiseaseFm]

Don’t miss the 2022 ESC Congress in Barcelona this month!

Hear the latest in the cardiology space from experts to better support heart health in patients with #ChronicKidneyDisease

Sign up here:

[Chinamedonline @Chinamed01]

Xinhua Medical (https://t.co/LuE1DEP2vw) announced that the company recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the State Medical Products Administration and Shandong Drug Administration。

[Chinamedonline @Chinamed01]

The Mexico International Medical Device Exhibition 2022 will be held in Mexico City from August 31, 2022 to September 2, 2022, with an exhibition size of 17,000 square meters.

[Chinamedonline @Chinamed01]

Chinamedonline, a B2B digital platform for professional medical equipment export in China. It provides services for enterprises to expand overseas markets:24-hour online exhibition, digital exhibition, online negotiation, and efficient trade matching between suppliers and buyers

[Chinamedonline @Chinamed01]

The 2022 Medical Device Innovation Exhibition was successfully concluded on August 12.
Medical Fair China 2022 was held in Suzhou . At the same time, Ferryman Medical Forum and FTR4H Digital Medical Forum were held. BBS invited a number of medical industry well-known enterprises

[Chinamedonline @Chinamed01]

Chinamedonline China Medical Export Digital platform at 2022 Medical Fair China Exhibition Time: August 10-12, 2022 Venue: Suzhou International Expo Center
Hall B1 - Booth No. F41, welcome!
Eastson meet you in Suzhou!

[Chinamedonline @Chinamed01]

Analysis of IVD pipeline market in China
Growth trend: the number of Chinese secondary and tertiary hospitals is becoming more and more bigger .
The future development:Imports still account for the majority of market capacity, with Roche, Abbott and Siemens accounting for 80%.

[WHX Dubai @WHXDubai]

It's time to level up, get inspired, and redefine what is possible in healthcare. Arab Health brings you 3 new conference tracks.
Join the conversation of tomorrow's healthcare at #ArabHealth 2023. Reserve your spot today, register your interest: https://t.co/a9rK04JxYu

[Chinamedonline @Chinamed01]

DONT SEDENTARY!!!!!TRY TO CHANGE IT FOR LYING DOWN!!!!

[Chinamedonline @Chinamed01]

SITTING FOR TOO LONG REALLY KILL YOU !!!!!🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
A study by Chinese scholars published in the Journal JAMA, have shown that sitting for eight hours a day increases the risk of death by 20%.

[Chinamedonline @Chinamed01]

@AfricaFactsZone cool

[Chinamedonline @Chinamed01]

@gibbstiger32 die or no die ,its a problem🤣

[Itai Josh Rusike @Itairusike]

#FightForWhatCounts
#TheBeatContinues
@naczim @MoHCCZim @WHO_Zimbabwe @UNAIDSZimbabwe @FranceZimbabwe @edmnangagwa @MthuliNcube @nickmangwana

[Chinamedonline @Chinamed01]

Columbia🇨🇴Meditech 2022

[Chinamedonline @Chinamed01]

FIME 2022 will be held at The Miami Beach Convention Center on 2022/07/27-07/29, with an exhibition scale of 30,000 square meters！!!

[Chinamedonline @Chinamed01]

https://t.co/gdwdMRHY1N

[Chinamedonline @Chinamed01]

The company focuses on the development, manufacturing and marketing of visuality-related medical devices, such as endoscopy and therapy, airway management and anesthesia, safe infusion and pet veterinary products. We own the SmartScope brand and have obtained a number of patents.

[Chinamedonline @Chinamed01]

Colombia Medical Device Fair 2022 (VII Meditech 2022) is organized by Bogota Medical Association, Chamber of Commerce, and is billed as the largest medical device fair in Colombia.

[Chinamedonline @Chinamed01]

A phase I clinical trial of JWATM204 in the treatment of advanced hepatocellular carcinoma (HCC) has been initiated.

This is the first human study of JWATM204 designed to evaluate the safety, tolerability, dose-limit toxicity

[Chinamedonline @Chinamed01]

The first in China! Apg-5918, a novel high-potency EED inhibitor, has been approved for clinical trial by FDA and will be tested in humans for the first time